期刊文献+

组氨酸接枝聚介导的RNA干扰技术对大鼠肝脏主要组织相容性复合体Ⅱ类基因及其反式激活因子基因表达的抑制作用

The inhibiting effect on rat liver class Ⅱ major histocompatibility complex and its transactivator gene expression by histidine grafted poly vector-based RNA interference technology
原文传递
导出
摘要 目的 观察应用新型纳米载体组氨酸接枝聚(β-氨基酯)(HGPAEs)介导的RNA干扰技术对大鼠肝脏主要组织相容性复合体Ⅱ类基因(MHC-Ⅱ)及其反式激活因子基因(CⅡTA)表达的抑制作用.方法 构建HGPAEs及针对大鼠CⅡTA基因的短发夹RNA(shRNA)质粒,并将两者耦合成pCⅡTA-HGPAEs载体,分别设置生理盐水组、单纯HGPAEs组、pHK-HGPAEs阴性对照组和pCⅡTA-HGPAEs干预组,通过门静脉注射方法体内转染大鼠肝脏,分别采用荧光定量聚合酶链式反应(FQ-PCR)和Western blot检测转染后CⅡTA和MHC-Ⅱ基因的mRNA转录水平及蛋白表达水平.结果 成功构建载shRNA质粒的HGPAEs载体,体内转染大鼠肝脏后,pCⅡTA-HGPAEs组CⅡTA与MHC-Ⅱ基因的mRNA转录水平及蛋白表达水平显著下降(P<0.01),与生理盐水组比较,C ⅡTA及MHC-Ⅱ转录水平分别为(21.4±4.2)%和(26.3±5.8)%,蛋白表达水平分别为(21.6±7.6)%和(27.8±5.6)%.而生理盐水、HGPAEs、pHK-HGPAEs组转染后CⅡTA与MHC-Ⅱ基因mRNA转录水平及蛋白表达水平差异无统计学意义(P>0.05).结论 HGPAEs是一种较为理想的基因转运载体,应用RNA干扰技术经门静脉注射方法转染大鼠肝脏,可显著抑制CⅡTA和MHC-Ⅱ基因表达. Objective To investigate the inhibitory effect on rat liver class Ⅱ major histocompatibility complex (MHC-Ⅱ) and MHC-Ⅱ transactivator (C Ⅱ TA) gene expression by histidine grafted poly (β-amino ester) s(HGPAEs) vector-based RNA interference(RNAi) technology.Methods According to C Ⅱ TA genetic information,short hairpin RNA (shRNA) sequence was designed and the HGPAEs vectors were constructed.Coupled HGPAEs and shRNA plasmid vectors targeting C Ⅱ TA into pC Ⅱ TA-HGPAEs vectors.Totally 4 groups were set respectively:control group,HGPAEs control group,pHK-C Ⅱ TA control group and pC Ⅱ TA-HGPAEs group,received liver transfection through portal vein injection.Real-time PCR and Western blotting were performed to detect the expression of C Ⅱ TA and MHC-Ⅱ in liver 3 days after transfection.Results pC Ⅱ TA-HGPAEs vectors were successfully constructed.Compared with control groups,the mRNA transcription levels and the protein expression levels of C Ⅱ TA and MHC-Ⅱ were significantly inhibited in pC Ⅱ TA-HGPAEs group (P 〈 0.01).The mRNA expression levels ofC ⅡTA and MHC-]Ⅱ were (21.4 ±4.2)% and (26.3 ±5.8)%,and the protein expression levels were (21.6 ± 7.6) % and (27.8 ± 5.6) %.Conclusion HGPAEs vectors may be a promised gene carrier.The expression of rat liver C Ⅱ TA and MHC-Ⅱ can be obviously inhibited by pC Ⅱ TA-HGPAEs vectors.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2015年第4期753-756,共4页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(81102246) 教育部高等学校博士学科点专项科研基金资助项目(20101202120009) 天津市自然科学基金资助项目(13JCQNJC11900) 天津市教委科研基金资助项目(20090126)
关键词 组氨酸接枝聚(β-氨基酯) 主要组织相容性复合体Ⅱ类基因 主要组织相容性复合体Ⅱ类分子反式激活因子 RNA干扰 Histidine grafted poly(β-amino ester)s Class Ⅱ major histocompatibility complex Major histocompatibility complex class Ⅱ transactivator RNA interference
  • 相关文献

参考文献9

  • 1Soe KC, Devaiah BN, Singer DS. Transcriptional coactivator C B TA, a functional homolog of TAFI, has kinase activity [ J ]. Biochim Biophys Acta,2013,1829 ( 11 ) : 1184-1190.
  • 2Taschl T. Expanding small RNA interference[J]. Nat Biotechnol, 2002,20 ( 5 ) :446 -448.
  • 3Reith W, LeibundGut-Landmann S, Waldburger JM. Regulation of MHC class II gene expression by the class trmasactivator[J]. Nat Rev hnmuno1,2005,5 (10) :793-806.
  • 4Kiln TW, Choi YM, Seo JN, et al. Delayed allngratl rejection by the suppression of class II transactivator [ J ]. Exp Mol Meal, 2006,38 (3) :210-216.
  • 5田培超,刘玉峰,王怀立,罗强,陈铮,王越.靶向人神经母细胞瘤MYCN基因慢病毒载体的构建及鉴定[J].中华实验外科杂志,2014,31(8):1790-1793. 被引量:3
  • 6Yan R,Hallam A, Stockley PG, et al. Oncogene dependency and tile potential of targeted RNAi-based anti-cancer therapy [ J ]. Biochem J, 2014,461 (1) :1-13.
  • 7Oba M. Study on development of polymeric micellar gene cm'rier and evaluatinn of its functionality [ J ]. Binl Pharm Bnll, 2013,36 ( 7 ) : 1045-1051.
  • 8Yuan X, Naguib S, Wu Z. Recent advances of siRNA delively by nann- particles [ J ]. Expert Opin Dntg Deliv ,2011,8 ( 4 ) : 521-536.
  • 9曾林涓,钟淑萍,李学刚,林忠,黄开红,陈茵婷.载小干扰RNA纳米微粒沉默U937细胞B细胞淋巴瘤/白血病-2基因增加砷剂细胞毒效应的研究[J].中华实验外科杂志,2014,31(5):1101-1104. 被引量:3

二级参考文献26

  • 1李臣宾 ,张峰 ,史玉荣 ,魏熙胤 ,杨毅 ,牛瑞芳 .小干扰RNA引发多药耐药乳腺癌细胞内MDR1基因沉默的研究[J].中华实验外科杂志,2004,21(10):1199-1201. 被引量:18
  • 2Katayose S, Kataoka K. Remarkable increase in nuclease resistance of plasmid DNA through supramoleeular assembly with poly (ethylene glycol) -puly (L-lysine) block copolymer [ J ]. J Pharm Sci, 1998,87 (2) :160-163.
  • 3Harada-Shiba M, Yamauchi K, Harada A, et al. Polyion complex mi- celles as vectors in gene therapy-pharmacokinetics and in vivo gene transfer [ J ]. Gene Ther,2002,9 ( 6 ) :407-414.
  • 4Zeng L, Li J,Wang Y,et al. Combination of siRNA-directcd Kras on- eogene silencing and arsenic-induced apoptosis using a nanomedicine strategy for the effective treatment of pancreatic cancer [ J ]. Nanomcd- ieine,2014,10(2) :463-472.
  • 5Qian C,Wang Y, Chen Y, et al. Suppression of panereatie tumor growth by targeted arsenic delivery with anti-CIM4v6 single chain antibody con- jugated nmloparticles [ J ]. Biomaterials,2013,34 ( 26 ) :6 75 -6 84.
  • 6Chen AM,Zhang M,Wei D, et al. Co-delivery of doxorubicin and b.l-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in mulddrug-resistant cancer ceils [ J ]. Small, 2009,5 ( 23 ) :2673-2677.
  • 7Jung HJ,Chen Z, Mccarty N. Synergistic antieancer effeets of arsenic trioxide with hortezomib in mantle cell lymphonla[ J ]. Am J tlelnalol, 2012,87(12) :1057-1064.
  • 8Cui X, Wakai T, Shirai Y ,et al. Arsenic trioxide inhibits DNA methyl- transferase and restores methylalion-silenced genes in human liver cancer cells [ J ]. Hum Pathol,2006,37 ( 3 ) : 298-311.
  • 9Lebedeva IV, Su ZZ, Sarkar D, ct al. Induction of reac-tive oxygen spe- cies renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad. mda-7-induced apoptosis [ J ]. Oneogene, 2005,24 (d) :585-596.
  • 10Perkins C, Kim CN, Fang G, et al. Arsenic induces apoptosis of nmlti- drug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, bcl-2, or bcl-x (L) [ J ]. Blood, 2000,95 (3) :1014-1022.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部